Sisram Medical Ltd (HKG:1696)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.250
0.00 (0.00%)
At close: Jan 21, 2026
20.40%
Market Cap1.99B
Revenue (ttm)2.71B
Net Income (ttm)161.71M
Shares Out468.34M
EPS (ttm)0.34
PE Ratio12.33
Forward PE6.62
Dividend0.13 (2.96%)
Ex-Dividend DateAug 26, 2025
Volume235,600
Average Volume510,162
Open4.250
Previous Close4.250
Day's Range4.200 - 4.290
52-Week Range3.310 - 8.070
Beta1.02
RSI42.79
Earnings DateMar 20, 2026

About Sisram Medical

Sisram Medical Ltd engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio for various wellness businesses, including hair growth and removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue... [Read more]

Sector Healthcare
Founded 2013
Employees 1,015
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1696
Full Company Profile

Financial Performance

In 2024, Sisram Medical's revenue was $349.11 million, a decrease of -2.83% compared to the previous year's $359.29 million. Earnings were $25.13 million, a decrease of -20.23%.

Financial numbers in USD Financial Statements

News

Half Year 2025 Sisram Medical Ltd Earnings Call Transcript

Half Year 2025 Sisram Medical Ltd Earnings Call Transcript

2 months ago - GuruFocus

Sisram Medical reports 1H results

5 months ago - Seeking Alpha

Sirsram Medical announces NMPA approval for DAXXIFY®

Marking the introduction of the world's first and only peptide-powered botulinum toxin product to Mainland China HONG KONG , Sept. 9, 2024 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading in...

1 year ago - Benzinga